Introduction Type 2 diabetes mellitus (T2DM) requires long-term pharmacologic therapy, with treatment choice influenced by efficacy, tolerability, and safety (1). Metformin is the first-line agent, but alternative or combination therapies are often necessary (1). Dipeptidyl peptidase-4 (DPP-4) inhibitors have become attractive options owing to weig
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2385 Reached7 Comments4 Likes
Managing Amenorrhea in Adolescent girl
2545 Reached5 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes